about
Biochemical Markers of Physical Exercise on Mild Cognitive Impairment and Dementia: Systematic Review and PerspectivesA mechanism for lipid binding to apoE and the role of intrinsically disordered regions coupled to domain-domain interactions.The effectiveness and unique contribution of neuropsychological tests and the δ latent phenotype in the differential diagnosis of dementia in the uniform data set.Influence of domain stability on the properties of human apolipoprotein E3 and E4 and mouse apolipoprotein E.Identification of misdiagnosed fronto-temporal dementia using APOE genotype and phenotype-genotype correlation analyses.Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysisQuantitative proteomics identifies host factors modulated during acute hepatitis E virus infection in the swine model.SIRT1 in the brain-connections with aging-associated disorders and lifespanAmyloid β oligomers in Alzheimer's disease pathogenesis, treatment, and diagnosis.Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA.ApoE4-specific Misfolded Intermediate Identified by Molecular Dynamics Simulations.Structural stability and functional remodeling of high-density lipoproteins.Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit.Alzheimer's disease: presence and role of microRNAs.Nutrition in early life and the programming of adult disease: a review.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Amyloid-Forming Properties of Human Apolipoproteins: Sequence Analyses and Structural InsightsPromising Targets for the Treatment of Neurodegenerative Diseases.Association between dietary patterns and cognitive function among 70-year-old Japanese elderly: a cross-sectional analysis of the SONIC study.Association of Parkinson's Disease GWAS-Linked Loci with Alzheimer's Disease in Han Chinese.Apolipoprotein E epsilon 4 (APOE-ε4) genotype is associated with decreased 6-month verbal memory performance after mild traumatic brain injury.Helical structure, stability, and dynamics in human apolipoprotein E3 and E4 by hydrogen exchange and mass spectrometry.Association of HLA-DRB1 polymorphism with Alzheimer's disease: a replication and meta-analysis.Atomistic Insights into Structural Differences between E3 and E4 Isoforms of Apolipoprotein E.Molecular Mechanisms of the R61T Mutation in Apolipoprotein E4: A Dynamic Rescue.Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer's disease.Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer's Disease.Class I HDAC inhibition is a novel pathway for regulating astrocytic apoE secretion.Apolipoprotein E levels in pediatric patients undergoing cardiopulmonary bypass.
P2860
Q26784555-51B9B4F6-9182-4200-9720-F4D367F138B9Q30402554-A0394AE4-84F7-4646-88A3-E363984FCDFAQ31140102-9972D121-B415-49EA-B98E-FE806E140466Q33807188-2E064EC2-A73F-4E1C-8041-58F9D87DB75DQ33837891-1AC0CB7B-D1F5-4DD0-93A2-18379AD0AE31Q34410256-71824EBA-3016-456F-854E-E88821C132C4Q34992525-AE9CBF74-42A0-430A-8581-851C706FB1A1Q35158382-07F01151-0E0A-419B-9F4E-A87C2EAD6A01Q35327172-BB941A61-7E74-4016-A169-1CCF87329537Q35507433-E08F8D86-8DB6-4F1F-97AA-5A913CD6E92BQ35823248-D32D22C7-46EE-4774-A739-870356BBBD7FQ36031087-56D9AB89-C027-44A9-B590-29E189F0CFA0Q36885357-D64822FD-DC0D-4A80-9D32-A7267A380C31Q37280174-2881D8C9-8747-432C-ACF3-9467673B1521Q38183429-7EF0CC2A-17B8-46C6-9718-7CDDB402E8D3Q38256360-C5E1A87A-F6D3-4FF1-8ECE-39CA7033CD1EQ38543425-120F43E2-6E50-450C-81BE-67A6F6C4863EQ38562084-6C8F3368-B256-46C8-87BF-4C72244797CFQ40047305-9179391A-5F0C-47A4-922C-AD32D56FD20BQ40135749-D40F1D3C-2E4A-4F33-A4FA-F86AD2A5C5C3Q41691286-6206945C-6FD1-4C8B-A7E2-E259C863AEB6Q42323951-969F93A0-B97D-4382-80E9-1D46B8C725A5Q47162013-250BC403-7F49-4AFF-B5BB-FEC78F8EBD19Q47270627-175F690B-6156-4637-BFEC-D5F603F00750Q47794190-B2A3C2DE-8190-40F6-AB8B-F0A660822495Q48217870-6DD32DDD-C47A-49C1-9A8A-E760B3D4A544Q50563445-7212F91E-E5F0-49DD-B4C5-7591AD1C7E32Q52631118-A94664C0-9A71-468C-8884-536646D357F6Q53627025-5435BC15-B050-405E-BCDC-B80E7C7B6E63
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Impact of apolipoprotein E on Alzheimer's disease
@ast
Impact of apolipoprotein E on Alzheimer's disease
@en
Impact of apolipoprotein E on Alzheimer's disease
@nl
type
label
Impact of apolipoprotein E on Alzheimer's disease
@ast
Impact of apolipoprotein E on Alzheimer's disease
@en
Impact of apolipoprotein E on Alzheimer's disease
@nl
prefLabel
Impact of apolipoprotein E on Alzheimer's disease
@ast
Impact of apolipoprotein E on Alzheimer's disease
@en
Impact of apolipoprotein E on Alzheimer's disease
@nl
P2860
P1476
Impact of apolipoprotein E on Alzheimer's disease
@en
P2093
Paul S Hauser
P2860
P304
P356
10.2174/15672050113109990156
P407
P577
2013-10-01T00:00:00Z